Literature DB >> 27935329

Update on bipolar disorder biomarker candidates: what about uric acid/adenosine hypothesis?

Francesco Bartoli1, Giuseppe Carrà1,2, Massimo Clerici1.   

Abstract

Entities:  

Keywords:  Uric acid; adenosine; biomarkers; bipolar disorder; mania

Mesh：

Substances：

Year:  2016        PMID： 27935329     DOI： 10.1080/14737159.2017.1270757

Source DB:  PubMed          Journal:  Expert Rev Mol Diagn        ISSN： 1473-7159            Impact factor:   5.225


× No keyword cloud information.
  5 in total

Review 1.  Antioxidant uric acid in treated and untreated subjects with major depressive disorder: a meta-analysis and meta-regression.

Authors:  Francesco Bartoli; Giulia Trotta; Cristina Crocamo; Maria Rosaria Malerba; Massimo Clerici; Giuseppe Carrà
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-15       Impact factor: 5.270

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  Identification of potential plasma protein biomarkers for bipolar II disorder: a preliminary/exploratory study.

Authors:  Sheng-Yu Lee; Tzu-Yun Wang; Ru-Band Lu; Liang-Jen Wang; Sung-Chou Li; Chi-Ying Tu; Cheng-Ho Chang; Yung-Chih Chiang; Kuo-Wang Tsai
Journal:  Sci Rep       Date:  2021-05-04       Impact factor: 4.379

4.  Are Mannan-binding Lectine Serin Protease-2 and Alpha-1-microglobulin and Bukinin Precursor the Potential Biomarkers of Manic Episode? A Study via Urinary Proetomic Analysis.

Authors:  Cem Cerit; Mehmet Sarıhan; Ömer Nart; Murat Kasap; Hilmi Yaşar; Gürler Akpınar
Journal:  Clin Psychopharmacol Neurosci       Date:  2021-05-31       Impact factor: 2.582

5.  The prevalence and associated clinical correlates of hyperuricemia in patients with bipolar disorder.

Authors:  Shuyun Li; Xiaobing Lu; Xiaodong Chen; Zebin Huang; Hui Zhou; Zezhi Li; Yuping Ning
Journal:  Front Neurosci       Date:  2022-09-16       Impact factor: 5.152
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.